Mitigation of biases in estimating hazard ratios under non-sensitive and non-specific observation of outcomes–applications to influenza vaccine effectiveness | Emerging Themes in Epidemiology | Full Text
Vaccines | Free Full-Text | Influenza–Host Interplay and Strategies for Universal Vaccine Development | HTML
Frontiers | Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Why WHO Skipped Two Letters of the Greek Alphabet in Naming Omicron | Coronavirus | wevv.com
Kappa and Lambda Light Chains - HealthTree for Myeloma
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine